[HTML][HTML] The combination of multi-approach studies to explore the potential therapeutic mechanisms of imidazole derivatives as an MCF-7 inhibitor in therapeutic …

M Rashid, A Maqbool, N Shafiq, YA Bin Jardan… - Frontiers in …, 2023 - frontiersin.org
Breast cancer covers a large area of research because of its prevalence and high frequency
all over the world. This study is based on drug discovery against breast cancer from a series …

In silico studies on potential MCF-7 inhibitors: a combination of pharmacophore and 3D-QSAR modeling, virtual screening, molecular docking, and pharmacokinetic …

B Badhani, R Kakkar - Journal of Biomolecular Structure and …, 2017 - Taylor & Francis
Gallic acid and its derivatives exhibit a diverse range of biological applications, including
anti-cancer activity. In this work, a data-set of forty-six molecules containing the galloyl …

[PDF][PDF] Plant derived bioactive compounds, their anti-cancer effects and in silico approaches as an alternative target treatment strategy for breast cancer: An updated …

V Shrihastini, P Muthuramalingam, S Adarshan… - 2021 - researchgate.net
Cancer is one of the most common malignant diseases that occur worldwide, among which
breast cancer is the second leading cause of death in women. The subtypes are associated …

Design, synthesis, and computational validation of novel compounds selectively targeting HER2-expressing breast cancer

SA Elseginy, R Hamdy, V Menon, AM Almehdi… - Bioorganic & Medicinal …, 2020 - Elsevier
Human epidermal growth factor receptor (HER) is a family of multidomain proteins that plays
important role in the regulation of several biological functions. HER2 is a member of HER …

Exploring the Potential of Substituted 4-Thiazolidinone Derivatives in the Treatment of Breast Cancer: Synthesis, Biological Screening and In Silico Studies

G Teli, P Sharma, PA Chawla - Polycyclic Aromatic Compounds, 2023 - Taylor & Francis
A series of 4-thiazolidinone conjugates bearing quinoline/indole/furan scaffolds were
designed as potential anti-breast cancer agents, synthesized, and investigated for their anti …

[HTML][HTML] Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An …

V Shrihastini, P Muthuramalingam, S Adarshan… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is one of the leading causes of death among women
worldwide. Breast cancer may be provoked due to several physical, chemical and …

[PDF][PDF] Insight on the in silico study and biological activity assay of chalcone-based 1, 5-benzothiazepines as potential inhibitor for breast cancer MCF7. CMUJ

N Frimayanti, M Yaeghoobi, I Ikhtiarudin, DRW Putri… - Nat. Sci, 2021 - cmuj.cmu.ac.th
In silico study was performed to twelve 1, 5-benzothiazepine chalcone derivatives with the
protein target from the crystallographic structure modeling of the enzyme tyrosine kinase …

[HTML][HTML] Screening of phytochemicals as potential inhibitors of breast cancer using structure based multitargeted molecular docking analysis

V Jha, S Devkar, K Gharat, S Kasbe, DK Matharoo… - Phytomedicine …, 2022 - Elsevier
Background: Breast cancer being one of the most common cancers in women all around the
world is a dominant cause of deaths occurring all around the globe. The available potent …

Generating a potent inhibitor against MCF7 breast cancer cell through artificial intelligence based virtual screening and molecular docking studies

V Latha, V Gomathi, A Rajeshkanna - Indian Journal of …, 2023 - or.niscpr.res.in
Artificial Intelligence (AI) has been widely adopted by pharmaceutical industry to aid
rationally drug design and development by fostering the quick delivery of drug targets with …

Predictive hybrid paradigm for cytotoxic activity of 1, 3, 4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural …

PO Chukwuemeka, HI Umar, O Iwaloye… - Journal of …, 2022 - Taylor & Francis
The dysregulation of cyclin-CDK6 interactions has been implicated in human breast cancer,
providing a rationale for more therapeutic options. Recently, ATP-competitive inhibitors have …